Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19
- 1 November 2020
- journal article
- letter
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 418, 117106
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- SARS-CoV-2 infection: The role of cytokines in COVID-19 diseaseCytokine & Growth Factor Reviews, 2020
- Myasthenic crisis in COVID-19Journal of the Neurological Sciences, 2020
- Pyrexia-associated Relapse in Chronic Inflammatory Demyelinating PolyradiculoneuropathyInternal Medicine, 2018
- Myasthenia gravis and infectious diseaseJournal of Neurology, 2018
- Infections and multiple sclerosis2014
- Chronic Inflammatory Demyelinating PolyneuropathyCurrent Treatment Options in Neurology, 2013
- Dysregulated Epstein-Barr virus infection in patients with CIDPJournal of Neuroimmunology, 2010
- European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve SocietyEuropean Journal of Neurology, 2006
- Th1 shift in CIDP versus Th2 shift in vasculitic neuropathy in CSFJournal of the Neurological Sciences, 2005